At OMRF, Shah will serve as a technology development specialist.
Technology Ventures News
OMRF brain tumor drug receives rare disease designations from the FDA
The drug treats fast-growing, deadly brain cancers with no effective treatment.
Progentec Raises $5M in Series A Funding Led by Plains Venture Partners
Seeking new ways to help patients manage lupus
New use for OMRF brain cancer treatment could extend lives
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
FDA approves new sickle cell drug with Oklahoma roots
Adakveo significantly reduces pain crises in sickle cell patients.
Progentec Raises Funds to Support Advances in Lupus Detection and Management
The funding will help bring Progentec’s tool for identifying lupus flare ups and a biomarker-based disease-activity index closer to commercialization.
